The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
TAMPA, Fla. — For the first time this school year, the state offered the new Step Up for Students scholarships. One of them is specifically for families who choose to homeschool. It provides access to ...
The most common side effects of IV lecanemab are headache, infusion-related reactions, and amyloid-related imaging abnormalities, a side effect known to occur with the class of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results